APA (7th ed.) Citation

M, A., K, M., D, K., K, K., Y, K., T, S., . . . W, A. (2024). Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine. IScience, 27(2), 108964. https://doi.org/10.1016/j.isci.2024.108964

Chicago Style (17th ed.) Citation

M, Aboshi, et al. "Safety and Immunogenicity of VLPCOV-02, a SARS-CoV-2 Self-amplifying RNA Vaccine with a Modified Base, 5-methylcytosine." IScience 27, no. 2 (2024): 108964. https://doi.org/10.1016/j.isci.2024.108964.

MLA (9th ed.) Citation

M, Aboshi, et al. "Safety and Immunogenicity of VLPCOV-02, a SARS-CoV-2 Self-amplifying RNA Vaccine with a Modified Base, 5-methylcytosine." IScience, vol. 27, no. 2, 2024, p. 108964, https://doi.org/10.1016/j.isci.2024.108964.